PeptideDB

Biotinyl-Atrial Natriuretic Factor (1-28) (human)

CAS No.: 1815618-06-4

Biotinyl-Atrial Natriuretic Factor (1-28) (human) also called Biotinyl-carperitide, Biotin-Atrial Natriuretic Peptide (1
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

CAS 1815618-06-4
Sequence Biotinyl-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond)
Sequence Single Biotinyl-SLRRSSCFGGRMDRIGAQSGLGCNSFRY
Molecular Formula C137H217N47O41S4
Molecular Weight 3306.75
Synonyms Biotinyl-carperitide, Biotin-Atrial Natriuretic Peptide (1-28), human, porcine
Technology Synthetic
Storage -20°C, avoid light, cool and dry place
Application Biotinylated Peptides|Cardiovascular System & Diseases
Description Biotinyl-Atrial Natriuretic Factor (1-28) (human) also called Biotinyl-carperitide, Biotin-Atrial Natriuretic Peptide (1-28), human, porcine, one of three mammalian natriuretic peptides (NPs), has endocrine effects on fluid homeostasis and blood pressure. Atrial Natriuretic Peptide has the potential for cardiovascular diseases research.
References 1.  Natriuretic peptide drug leads from snake venom. S Vink, et al. 2012 Mar 15;59(4):434-45. 2.  Participation of glucose transporters on atrial natriuretic peptide-induced glucose uptake by adult and neonatal cardiomyocytes under oxygenation and hypoxia. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Verónica Sosa, et al. Eur J Pharmacol. 2007 Jul 30;568(1-3):83-8.